Roche Holding AG
SIX:ROG
Roche Holding AG
Cash from Investing Activities
Roche Holding AG
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Cash from Investing Activities
-CHf10.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-23%
|
|
Novartis AG
SIX:NOVN
|
Cash from Investing Activities
-$5.9B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-104%
|
CAGR 10-Years
-17%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Cash from Investing Activities
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Cash from Investing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Cash from Investing Activities?
Cash from Investing Activities
-10.6B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Cash from Investing Activities amounts to -10.6B CHF.
What is Roche Holding AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-23%
Over the last year, the Cash from Investing Activities growth was -264%. The average annual Cash from Investing Activities growth rates for Roche Holding AG have been -5% over the past three years , -8% over the past five years , and -23% over the past ten years .